PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $234,000 | +18.2% | 69,050 | -13.8% | 0.00% | 0.0% |
| Q2 2017 | $198,000 | +3.1% | 80,093 | -5.7% | 0.00% | 0.0% |
| Q1 2017 | $192,000 | +1.6% | 84,970 | -4.8% | 0.00% | 0.0% |
| Q4 2016 | $189,000 | -58.4% | 89,289 | -34.1% | 0.00% | 0.0% |
| Q3 2016 | $454,000 | -76.0% | 135,542 | -77.5% | 0.00% | -83.3% |
| Q2 2016 | $1,892,000 | -25.5% | 602,297 | -21.0% | 0.01% | -25.0% |
| Q1 2016 | $2,538,000 | -62.2% | 762,072 | -59.8% | 0.01% | -60.0% |
| Q4 2015 | $6,711,000 | -36.9% | 1,896,221 | -10.3% | 0.02% | -39.4% |
| Q3 2015 | $10,635,000 | -34.0% | 2,114,270 | -15.6% | 0.03% | -17.5% |
| Q2 2015 | $16,109,000 | +59.2% | 2,505,044 | +74.2% | 0.04% | +66.7% |
| Q1 2015 | $10,116,000 | +17.0% | 1,437,647 | +28.2% | 0.02% | +9.1% |
| Q4 2014 | $8,647,000 | +26.0% | 1,121,615 | +22.1% | 0.02% | +37.5% |
| Q3 2014 | $6,864,000 | -49.1% | 918,860 | -34.1% | 0.02% | -52.9% |
| Q2 2014 | $13,497,000 | +202.1% | 1,394,345 | +159.3% | 0.03% | +161.5% |
| Q1 2014 | $4,468,000 | -38.9% | 537,675 | -37.9% | 0.01% | -40.9% |
| Q4 2013 | $7,313,000 | -50.2% | 866,425 | -53.0% | 0.02% | -58.5% |
| Q3 2013 | $14,694,000 | +144.9% | 1,843,760 | +137.3% | 0.05% | +112.0% |
| Q2 2013 | $5,999,000 | – | 777,126 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |